GlassScriptPhysician profile
Bernadette R Anderson
NPI 1750366035
$1,851.76
in general payments reported to CMS, 2019-2025
16 companies · $621 in 2025
The $621 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $47.21 · 2021: $24.81 · 2023: $65.38 · 2024: $461 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $778.76 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Merck Sharp & Dohme LLC | $239.29 | 2019-2025 | Gardasil 9, Capvaxive |
| Novo Nordisk INC | $217.47 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $103.54 | 2023-2025 | Ubrelvy, Qulipta |
| Xeris Pharmaceuticals, INC. | $82.95 | 2024-2025 | Gvoke Hypopen |
| Abbott Laboratories | $72.69 | 2024-2025 | Freestyle Libre 3 |
| Shield Therapeutics INC | $65.45 | 2023-2025 | Accrufer |
| Amgen INC. | $65.12 | 2024-2025 | Otezla, Repatha, Evenity |
| Exact Sciences Corporation | $60.43 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $49.61 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Glaxosmithkline, LLC. | $36.26 | 2024 | Shingrix, Arexvy |
| Boston Scientific Corporation | $25.57 | 2025 | Watchman Access System |
| Kowa Pharmaceuticals America, INC. | $16.21 | 2025 | Zoryve |
| Phathom Pharmaceuticals, INC. | $15.91 | 2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $11.56 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernadette Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.